David Goggin has primary responsibility for the Company’s finances and operations. Before joining ImmunoProp, David served as CFO of Entelos, a computational biology company. His background includes nine years in investment banking with Deutsche Bank and CIBC World Markets (now Oppenheimer), where he advised specialty pharmaceutical, biotechnology and medical technology companies. David is a CPA and holds an MBA from Columbia University.

Dr. Enlander is an internal medicine physician based in New York City. He is considered one of the world’s leading authorities in chronic fatigue syndrome and fibromyalgia.

He serves on the faculty of Mount Sinai Medical School and is President of the Israel Medical Research Foundation.

Dr. Enlander holds an M.D. degree from Stanford University. He is the editor of an international peer reviewed medical journal, The Fatigue Journal.

Barry Cohen is a retired pharmaceutical executive. Mr. Cohen was a Senior Vice President of Merck and President of Merck Sharp & Dohme, with responsibilities for the sale of Merck’s prescription drugs in Europe, Japan and the Middle East.

Since 1994, Mr. Cohen has served as Chairman of the Board of Vasomedical. He has also served as a director of Akzo Nobel, Chugai Pharmaceutical, Neurobiological Technologies, and Teva Pharmaceutical.